Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2003
04/24/2003US20030079253 Immunoglobulin binding protein arrays in eukaryotic cells
04/24/2003US20030079244 Therapeutic agent for use in the treatment glandular disorders
04/24/2003US20030079238 Polynucleotide encoding a human junctional adhesion protein (JAM-2)
04/24/2003US20030079237 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
04/24/2003US20030079236 Polymorphisms associated with internalizing disorders
04/24/2003US20030078405 47 human secreted proteins
04/24/2003US20030078402 Expression library for use in the generation of preferential immunoglobulins
04/24/2003US20030078398 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
04/24/2003US20030078389 Gamma-heregulin
04/24/2003US20030078388 Antibody mixture for use in human diagnostics and therapeutics
04/24/2003US20030078387 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030078386 Antibody for use in the treatment of viral, gastrointestinal, autoimmune and cell proiferative disorders
04/24/2003US20030078385 Method for making multispecific antibodies having heteromultimeric and common components
04/24/2003US20030078384 Preparation and recovery of immunoglobulins; provide blood, suspend in ethanol, adjust hydrogen ion concentration, extract immunoglobulins using liquid-solid separation, remove impurities, deactivate viruses, recover immunoglobulins
04/24/2003US20030078381 Composition for use in the detection and treatment of cancer
04/24/2003US20030078378 Blocking expression of virulence factors in S. aureus
04/24/2003US20030078377 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030078376 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
04/24/2003US20030078375 Nucleotide sequences coding polypeptides for use in the tratment of ischemia-reperfusion injury, restenosis and parasitic diseases
04/24/2003US20030078373 Chaperone fragments
04/24/2003US20030078222 Human receptor tyrosine kinase
04/24/2003US20030078218 Use of receptor gene designated EX20, the protein molecule encoded by EX20 and related molecules in therapeutic and diagnostic applications
04/24/2003US20030078203 Covalently reactive transition state analogs and methods of use thereof
04/24/2003US20030077841 Therapeutic potential of immunoglobulin preparations
04/24/2003US20030077826 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
04/24/2003US20030077809 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, inflammation and skin disorders
04/24/2003US20030077802 Human PRL1 phosphatase
04/24/2003US20030077792 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077791 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077790 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077789 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077788 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077787 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077786 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077785 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077784 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077783 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077782 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077781 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077780 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077779 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077778 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077777 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077776 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077758 Myc repressor modulation to treat aging-related disorders
04/24/2003US20030077757 Method of treating aging-related disorders
04/24/2003US20030077756 Identification and modification of immunodominant epitopes in polypeptides
04/24/2003US20030077751 Polypeptide for use in the treatment of blood disorders
04/24/2003US20030077750 Peptide for use in human therapeutics and diagnostics
04/24/2003US20030077749 Ucp5
04/24/2003US20030077745 ps20 amino acid sequences
04/24/2003US20030077739 Generation of preferential antibody; obtain nucleotide sequences coding antibody, insert into vector, transform vector into cell, express vector, recover antibody
04/24/2003US20030077736 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077735 Novel human Kchannel and therapeutic applications thereof
04/24/2003US20030077734 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
04/24/2003US20030077728 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077727 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077726 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077725 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077724 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077723 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077722 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077721 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077720 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077719 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077718 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077717 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077716 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077715 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077714 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077713 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077712 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077711 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077710 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077706 Mouse cytokine receptor
04/24/2003US20030077700 Nucleotide sequences coding polypeptide for use in the treatment of tumors, nervous system amd liver disordrs
04/24/2003US20030077698 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077676 Anti-MUC-1 single chain antibodies for tumor targeting
04/24/2003US20030077668 Diagnosing arteriosclerosis in humans; obtain blood sample, incubate with preferential antibody, detect complex formation, determine concentration, evaluate for arteriosclerosis
04/24/2003US20030077663 Antibody discriminates between active and inactive conformations of growth hormone receptor
04/24/2003US20030077661 ATM kinase compositions and methods
04/24/2003US20030077659 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorders
04/24/2003US20030077657 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077654 Nucleotide sequences coding polypeptide for use in the treatment of nephritis, cancer and skin disorders
04/24/2003US20030077652 CDNA (complementary DNA) that encodes glycoprotein receptor from the tobacco hornworm which binds a Bacillus thuringiensis toxin; pesticides
04/24/2003US20030077644 Diagnosis and treatment of diseases caused by mutations in CD72
04/24/2003US20030077624 Diagnosing cancer in mammals; obtain sample cells, monitor expression of collapsin protein, amplified concentration of collapsin indicates cancer
04/24/2003US20030077613 Method for in vitro molecular evolution of protein function
04/24/2003US20030077594 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders
04/24/2003US20030077593 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders
04/24/2003US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection
04/24/2003US20030077579 Diagnostic assay
04/24/2003US20030077578 Diagnostic assay
04/24/2003US20030077568 Screening drugs; obtain cell with preferential phenotypic profile, incubate with drug, monitor effect on cells
04/24/2003US20030077292 Detection and treatment of cancers of the lung
04/24/2003US20030077287 Methods to improve immunogenicity of antigens and specificity of antibodies
04/24/2003US20030077286 A T cell receptor ligand which substantially inhibits at least one T cell effector response evoked by fully active peptide-MHC(major histocompatibility complex) available to respond T cells
04/24/2003US20030077285 Methods of diagnosis and treatment by binding p75/airm1
04/24/2003US20030077284 Contacting a B cell antigen receptor, pre-B cell receptor, pro-B cell receptor, Ig Fc receptors, and NK receptors, with a regulatory compound, causes dissociation of extracellular ligand binding component from transducer component
04/24/2003US20030077283 Topical treatment of psoriasis using neutralizing antibodies to IL-8